Tag Archives: CIPA

Cardiac Safety – the regulatory perspective

Dr Krishna Prasad, MHRA Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link).     Krishna reviewed the status quo pointing out that the regulations were a success in that no drugs having undergone E14 … Continue reading

Comments Off on Cardiac Safety – the regulatory perspective